On Monday, Immix Biopharma Inc (NASDAQ: IMMX) was -12.23% drop from the session before settling in for the closing price of $7.07. A 52-week range for IMMX has been $1.34 – $7.73.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -43.61%. When this article was written, the company’s average yearly earnings per share was at -1.40%. With a float of $33.53 million, this company’s outstanding shares have now reached $52.70 million.
Immix Biopharma Inc (IMMX) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Immix Biopharma Inc stocks. The insider ownership of Immix Biopharma Inc is 35.90%, while institutional ownership is 5.49%. The most recent insider transaction that took place on Dec 10 ’25, was worth 4,976. In this transaction CEO and Chairman of this company bought 746 shares at a rate of $6.67, taking the stock ownership to the 1,141,683 shares. Before that another transaction happened on Dec 10 ’25, when Company’s CFO bought 770 for $6.58, making the entire transaction worth $5,067. This insider now owns 291,429 shares in total.
Immix Biopharma Inc (IMMX) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.15 earnings per share (EPS) during the time that was better than consensus figure (set at -0.25) by 0.1. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -1.40% per share during the next fiscal year.
Immix Biopharma Inc (NASDAQ: IMMX) Trading Performance Indicators
You can see what Immix Biopharma Inc (IMMX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.53.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.79, a number that is poised to hit -0.16 in the next quarter and is forecasted to reach -0.65 in one year’s time.
Technical Analysis of Immix Biopharma Inc (IMMX)
The latest stats from [Immix Biopharma Inc, IMMX] show that its last 5-days average volume of 2.11 million was superior to 0.34 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 80.97%.
During the past 100 days, Immix Biopharma Inc’s (IMMX) raw stochastic average was set at 73.66%, which indicates a significant increase from 61.39% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.68 in the past 14 days, which was higher than the 0.32 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.91, while its 200-day Moving Average is $2.58. Now, the first resistance to watch is $6.90. This is followed by the second major resistance level at $7.59. The third major resistance level sits at $8.02. If the price goes on to break the first support level at $5.78, it is likely to go to the next support level at $5.36. Assuming the price breaks the second support level, the third support level stands at $4.66.
Immix Biopharma Inc (NASDAQ: IMMX) Key Stats
There are 33,578K outstanding shares of the company, which has a market capitalization of 326.98 million. As of now, sales total 0 K while income totals -21,610 K. Its latest quarter income was 0 K while its last quarter net income were -7,590 K.
